Drug overdoses are psychologically traumatic events that can lead to symptoms of post-traumatic stress disorder (PTSD).

Immunization programs offered in low- and middle-income countries provide a high “return on investment” in terms of the economic costs of diseases that are prevented and the values of lives that would have been lost.

Noel R. Rose, MD, PhD, a longtime Johns Hopkins Bloomberg School of Public Health faculty member and researcher recognized as a father of autoimmune disease research, died Thursday. Rose, 92, died at home in Brookline, Massachusetts.

Shannon Frattaroli, PhD, MPH, has been named the next director of the Johns Hopkins Center for Injury Research and Policy.

Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) JPEO-CBRND, on behalf of the Defense Health Agency, for two nationwide clinical trials.

Children in low-income neighborhoods in Baltimore tended to have more asthma symptoms when levels of the synthetic chemical BPA in their urine were elevated, according to a study from JHSPH researchers and the School of Medicine.

The Johns Hopkins Bloomberg School of Public Health, with Bloomberg Philanthropies, today announced a free new online course to help public health officials implement strong contact tracing programs to break the chain of novel coronavirus transmission.

The Challenge Initiative (TCI), a global initiative based at the Johns Hopkins Bloomberg School of Public Health, has received grants totaling $18.1 million from Bayer AG and the Bill & Melinda Gates Foundation.

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein.

A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population.